STAGE III NON-SMALL-CELL LUNG CANCER
Clinical trials for STAGE III NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE III NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo targets tough cancers in early trial
Disease control CompletedThis study tested a combination of two drugs—sEphB4-HSA and pembrolizumab—in 42 people with advanced non-small cell lung cancer or head & neck cancer that had spread or returned. The goal was to see if the combo could shrink tumors better than standard treatments. Participants ha…
Matched conditions: STAGE III NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 26, 2026 07:21 UTC
-
New combo therapy shows promise for tough lung cancer
Disease control CompletedThis study looked at combining durvalumab (an immune-boosting drug) with a precise, high-dose radiation called SBRT for people with stage III lung cancer. The goal was to see if this combination after standard chemoradiation was safe and could help keep the cancer from coming bac…
Matched conditions: STAGE III NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC